You are here

Closure of full thickness burn wounds with bioengineered skin: a preclinical study

The aim of this study is to demonstrate safety and efficacy of autologous bioengineered skin incorporating (1) NovoSorb® polyurethane polymer or (2) platelet-derived hydrogel in closing full thickness wounds in a porcine wound model. This pilot study is scheduled to take place in 2022-2023 and precedes a human clinical trial due to begin 2023. Please contact us to initiate discussions 4-6 months prior to planned start date of research. This project is most suitable for those interested in a career in burn surgery or plastic & reconstructive surgery.
Essential criteria: 
Minimum entry requirements can be found here:
human skin equivalent; bioengineered skin; tissue engineering; burns; full thickness wounds
Central Clinical School » Surgery - Alfred
Available options 
Masters by research
Time commitment 
Top-up scholarship funding available 
Physical location 
Alfred Hospital

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.